Drug Application of Epimedin C in Treating Diabetic Liver Injury
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 陕西新修本草健康产业有限公司
- Publication Date
- 2021-02-12
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomedicine, and relates to the new effect of Epimedin C in treating complications of diabetic liver damage (abbreviated as diabetic liver damage), and its application in the preparation of drugs for treating diabetic liver damage. Background technique
[0002] In recent years, the incidence of diabetes has increased year by year, and it has become the third major disease that seriously endangers human life and health after cardiovascular and cerebrovascular diseases and tumors. Diabetic complications are an important cause of disability and death in patients. As an important organ of sugar and lipid metabolism, the liver has a very close relationship with diabetes. Diabetes may cause damage to the liver in many ways, leading to complications of liver damage. Due to the atypical clinical symptoms of diabetic liver injury and other reasons, it has not been paid much attention by the medical community in ...